Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hormone Receptor–Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7035Source: DataRank Database

Hormone Receptor–Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3 is a research paper published in Journal of the National Comprehensive Cancer Network (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.35)OA: bronzeTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Jeffrey R. Whiteaker ORCID,Brianna Nelson,Richard G. Ivey ORCID,Travis D. Lorentzen ORCID,Uliana J. Voytovich ORCID

Live enrichment

PubMed:37643636 PMC:PMC11051703 OpenAlex:https://openalex.org/W4386241615

NCI NIH HHS

Grant: HHSN261201500003I

NCI NIH HHS

Grant: R50 CA211499

NCI NIH HHS

Grant: HHSN261201500003C

NCI NIH HHS

Grant: U01 CA271407

NCI NIH HHS

Grant: U01 CA214114

FWCI

0.35

Citation Percentile

0.6%

Citation Trend

2025

bronze

journalhttps://jnccn.org/downloadpdf/journals/jnccn/21/11/article-p1110.pdf

publisherhttps://jnccn.org/downloadpdf/journals/jnccn/21/11/article-p1110.pdf

journalhttp://dx.doi.org/10.6004/jnccn.2023.7035

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37643636

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11051703

Fields of Study

Genetic factors in colorectal cancerCancer Genomics and DiagnosticsLung Cancer Treatments and Mutations

MeSH Terms

MutL Protein Homolog 1Breast NeoplasmsColonic NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisFemaleHumansVirulenceGerm-Line MutationAntibodies, Monoclonal, Humanized

Keywords

MLH1Microsatellite instabilityMedicineBreast cancerPembrolizumabOncologyLynch syndromeInternal medicineCancerLoss of heterozygosityMSH2Colorectal cancerCancer researchDNA mismatch repairBiologyGeneticsMicrosatellite

Sustainable Development Goals

SDG 0: Good health and well-being